Human BioSystems, Inc., a development stage company, focuses primarily on preservation solutions for biological materials, principally for blood platelets and donor organs. The company is developing technologies for preserving platelets, red blood cells, heart valves, and tissue, as well as organs, including kidney, hearts, livers, and lungs. Its technologies would extend the shelf life and improve the quality of blood platelets and other biological material. The company’s target customers include blood banks, hospitals, clinics, and similar organizations. It operates in the United States and Russia. Human BioSystems was formed in 1998 as HyperBaric Systems and changed its name to Human BioSystems, Inc. in 2002. The company is headquartered in Palo Alto, California.